Brandon Adcock is listed as CEO on LinkedIn with the Wellful company page showing 116 employees. Wellful is the parent company operating Adaptive Health, the entity behind Nugenix, Instaflex, and Peptiva brands. Charlotte, NC headquarters confirmed.
Dana Hayes is confirmed as CMO. Both are publicly verifiable on LinkedIn with full profiles.
Email pattern: first initial + last name at wellful.com. badcock@wellful.com is the confirmed format match. [CONFIRMED pattern]
Adaptive Health / Wellful is actively posting for a direct response copywriter on Indeed and LinkedIn as of March 2026. This is the highest-confidence outreach signal possible. They have diagnosed the gap themselves. They are spending money to fill it. Emko can bypass the job application entirely by contacting Brandon directly with the problem already framed and solved.
I ran the Nugenix funnel. Frank Thomas TV ads drive to nugenix.com/products/. The product pages have: no mechanism copy (why the ingredients work), no testimonials, no credibility stack, no urgency element, no benefit-focused headline.
The hero section is a product image with a generic tagline. It is not a DR landing page. It is a catalog page. Adaptive Health is spending on Frank Thomas national TV spots and sending all that traffic to a page that cannot convert.
The gap between ad creative quality and landing page quality is the reason they are hiring a DR copywriter right now.
Frank Thomas ad angle: authority + legitimacy + social proof. A respected athlete vouching for the product with specific credibility. The ad builds intent and trust.
Nugenix.com landing page angle: product features. No continuation of the story the ad started. No Frank Thomas credibility carried through. The viewer arrives in a trust vacuum after being warmed up by an expensive TV spot.
This is the fundamental DR copy gap: the ad and the landing page are not telling the same story. Conversion rates collapse at this seam.
The Instaflex product pages follow the same pattern. Strong TV creative drives traffic to product catalog pages. No VSL, no long-form landing page, no mechanism copy. The brand has differentiation that is never communicated on the page that takes the order.
Nugenix contains specific ingredients with clinical research behind them (zinc, fenugreek extract, Testofen). None of this is communicated on the landing pages. The ingredient science that differentiates the product from commodity testosterone supplements is buried or absent entirely.
Mechanism copy is not optional in the testosterone supplement space. Buyers have tried other products. They need to know why this one is different at the biochemical level. The absence of mechanism copy means every skeptical visitor leaves unconverted.
Nugenix has been on the market for years with substantial customer base. Almost certainly has result testimonials, before/after data, and review volume. None of this appears on the product pages. A DR landing page without a testimonial/proof section is missing its most important trust mechanism for first-time buyers.
The product pages have no urgency mechanism. No scarcity signal, no time-limited offer, no reason to buy today rather than tomorrow. DR copy depends on a close that moves the buying decision to right now. Without it, a significant percentage of visitors who intended to buy leave and do not return.